Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Q32 Bio Inc. (DB0.F)

1.5600
-0.0500
(-3.11%)
At close: April 25 at 3:49:30 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
-6,651
6,651
--
Operating Expense
66,102
66,102
41,604
45,876
36,693
Operating Income
-66,102
-66,102
-48,255
-39,225
-36,693
Net Non Operating Interest Income Expense
2,800
2,800
--
--
--
Other Income Expense
17,215
17,215
-5,170
-3,522
-324
Pretax Income
-46,087
-46,087
-53,425
-42,747
-37,017
Tax Provision
21
21
318
62
547
Earnings from Equity Interest Net of Tax
-1,625
-1,625
--
--
--
Net Income Common Stockholders
-47,733
-47,733
-53,743
-42,809
-37,564
Diluted NI Available to Com Stockholders
-63,533
-63,533
-53,743
-42,809
-37,564
Basic EPS
-5.12
--
-4.51
-3.59
-3.15
Diluted EPS
-6.58
--
-4.51
-3.59
-3.15
Basic Average Shares
9,320.8840
--
11,929.5280
11,929.5280
11,929.5280
Diluted Average Shares
9,657.6960
--
11,929.5280
11,929.5280
11,929.5280
Total Operating Income as Reported
-66,102
-66,102
-48,255
-39,225
-36,693
Total Expenses
66,102
66,102
41,604
45,876
36,693
Net Income from Continuing & Discontinued Operation
-47,733
-47,733
-53,743
-42,809
-37,564
Normalized Income
-59,733.1000
-59,733.1000
-48,850.5300
-40,407
-37,564
Interest Income
3,900
3,900
--
--
--
Interest Expense
1,100
1,100
--
--
--
Net Interest Income
2,800
2,800
--
--
--
EBIT
-44,987
-44,987
-48,255
-39,225
-36,693
EBITDA
-44,500
-44,500
-47,756
-38,855
-36,646
Reconciled Depreciation
487
487
499
370
47
Net Income from Continuing Operation Net Minority Interest
-47,733
-47,733
-53,743
-42,809
-37,564
Total Unusual Items Excluding Goodwill
15,190
15,190
-6,193
-2,402
--
Total Unusual Items
15,190
15,190
-6,193
-2,402
--
Normalized EBITDA
-59,690
-59,690
-41,563
-36,453
-36,646
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
--
Tax Effect of Unusual Items
3,189.9000
3,189.9000
-1,300.5300
--
--
12/31/2021 - 7/9/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2509.HK Qyuns Therapeutics Co., Ltd.
10.960
+3.59%
 
CLYM Climb Bio Inc
1.2700
-2.31%
 
EQ Equillium, Inc.
0.4382
-4.74%
 
HNSA.ST Hansa Biopharma AB (publ)
28.36
+19.76%
 
TVRD Tvardi Therapeutics, Inc.
18.85
+5.90%
 
SAGE Sage Therapeutics, Inc.
7.79
0.00%
 
FOLD Amicus Therapeutics, Inc.
7.35
+2.08%
 
AVTE Aerovate Therapeutics, Inc.
2.6800
-1.47%
 
XFOR X4 Pharmaceuticals, Inc.
0.1900
+1.50%
 
ONC BeiGene, Ltd.
244.90
-4.40%